Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Kummar, Shivaani"'
Autor:
Kummar S; Stanford Cancer Center, Stanford University, Palo Alto, California, USA., Shen L; Department of Gastrointestinal Oncology, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Peking University Cancer Hospital and Institute, Beijing, China., Hong DS; The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McDermott R; St. Vincent's University Hospital and Cancer Trials Ireland, Dublin, Ireland., Keedy VL; Vanderbilt University Medical Center, Nashville, Tennessee, USA., Casanova M; Paediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Demetri GD; Dana-Farber Cancer Institute and Ludwig Center at Harvard Medical School, Boston, Massachusetts, USA., Dowlati A; University Hospitals Ahuja Medical Center, Beachwood, Ohio, USA., Melcón SG; Pediatric Oncology and Hematology, Vall d'Hebron Children's Hospital, Barcelona, Spain., Lassen UN; Department of Oncology, Rigshospitalet, Copenhagen, Denmark., Leyvraz S; Charité-Universitätsmedizin Berlin, Berlin, Germany., Liu T; Zhongshan Hospital-Fudan University, Shanghai, China., Moreno V; START MADRID-FJD, Hospital Fundación Jiménez Díaz, Madrid, Spain., Patel J; Northwestern University, Chicago, Illinois, USA., Patil T; Department of Medicine, Division of Medical Oncology, University of Colorado, Aurora, Colorado, USA., Mallick AB; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Sousa N; Instituto Portugues de Oncologia do Porto Francisco Gentil, Porto, Portugal., Tahara M; National Cancer Center Hospital East, Kashiwa, Japan., Ziegler DS; Sydney Children's Hospital, Randwick, New South Wales, Australia.; Australia and School of Women's and Children's Health, University of New South Wales Sydney, Sydney, New South Wales, Australia., Norenberg R; Chrestos Concept GmbH & Co. KG, Essen, Germany., Arvis P; Bayer Pharmaceuticals, Loos, France., Brega N; Bayer Pharmaceuticals, Milan, Italy., Drilon A; Memorial Sloan Kettering Cancer Center, New York, New York, USA.; Weill Cornell Medical College, New York, New York, USA., Tan DSW; Division of Medical Oncology, National Cancer Centre Singapore, Duke-NUS Medical School, Singapore, Singapore.
Publikováno v:
Cancer [Cancer] 2023 Dec 01; Vol. 129 (23), pp. 3772-3782. Date of Electronic Publication: 2023 Sep 28.
A Phase I Study of Ganetespib and Ziv-Aflibercept in Patients with Advanced Carcinomas and Sarcomas.
Autor:
Meehan R; Early Clinical Trials Development Program, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Do K; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., O'Sullivan Coyne G; Early Clinical Trials Development Program, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Juwara L; Clinical Research Directorate/Clinical Monitoring Research Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, Maryland, USA., Zlott J; Early Clinical Trials Development Program, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Rubinstein L; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Doroshow JH; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA., Chen AP; Early Clinical Trials Development Program, Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland, USA chenali@mail.nih.gov.
Publikováno v:
The oncologist [Oncologist] 2018 Nov; Vol. 23 (11), pp. 1269-e125. Date of Electronic Publication: 2018 May 31.
Autor:
Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland., Blair DG; Division of Cancer Biology, National Cancer Institute, Rockville, Maryland., Anders CK; Department of Medicine, University of North Carolina, Chapel Hill, North Carolina., Bleyer WA; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon., Boardman LA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota., Khan J; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Kummar S; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland., Hayes-Lattin B; Division of Hematology and Medical Oncology, Oregon Health and Science University, Portland, Oregon., Hunger SP; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania., Merchant M; Center for Cancer Research, National Cancer Institute, Bethesda, Maryland., Seibel NL; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland., Thurin M; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, Maryland., Willman CL; University of New Mexico Cancer Center, Albuquerque, New Mexico.
Publikováno v:
Cancer [Cancer] 2016 Apr 01; Vol. 122 (7), pp. 1017-28. Date of Electronic Publication: 2016 Feb 05.